title: Palmar-plantar erythrodysesthesia secondary to sunitinib treatment resulting in necrotic foot syndrome aggravated by background diabetic vascular disease.
authors: Emmanuella
authors: E
authors: Guenova
authors: Hans Oliver
authors: HO
authors: Weber
authors: Bogmil
authors: B
authors: Voykov
authors: Gisela
authors: G
authors: Metzler
authors: Vanyo
authors: V
authors: Mitev
authors: Mark
authors: M
authors: Berneburg
authors: Wolfram
authors: W
authors: Hoetzenecker
authors: Martin
authors: M
authors: Röcken
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy; D003925:Diabetic Angiopathies; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005528:Foot / Q000473:pathology; D005534:Foot Diseases / Q000209:etiology / Q000473:pathology*; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D010292:Paresthesia / Q000209:etiology; D011758:Pyrroles / Q000009:adverse effects*; D012867:Skin / Q000473:pathology; D000077210:Sunitinib
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib